Tue, May 22, 2012
Folic acid tied to lower child cancer risks
By Amy Norton
NEW YORK (Reuters Health) - Rates of two rare childhood cancers declined after the U.S. began requiring grain products to be ...
Tue, May 22, 2012
Many babies with development delays may go untreated
By Kerry Grens
NEW YORK (Reuters Health) - About one out of every three infants who scores well below average on a test of developmental ...
Tue, May 22, 2012
Mom's excess pounds key in newborn weight
By Amy Norton
NEW YORK (Reuters Health) - For at least some moms-to-be, it's extra body fat -- and not blood sugar levels -- that may ...
Tue, May 22, 2012
Exercise tied to lower risk of psoriasis: study
By Genevra Pittman
NEW YORK (Reuters Health) - Results from a large U.S. study suggest women who regularly exercise vigorously, including runners and aerobics ...
Tue, May 22, 2012
Takeda drug impresses in ulcerative colitis study
By Bill Berkrot
(Reuters) - More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after ...
Tue, May 22, 2012
Eli Lilly's diabetes drug meets mid-stage trial goal
(Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test ...
Tue, May 22, 2012
FDA staff shoots down Pfizer rare disease drug
WASHINGTON (Reuters) - Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a ...
Tue, May 22, 2012
Bavarian Nordic says U.S. backs new Imvamune study
COPENHAGEN (Reuters) - Danish biopharma firm Bavarian Nordic said on Tuesday that the U.S. Department of Health and Human Services has supported the initiation ...
Tue, May 22, 2012
Ramadan sets Muslim athletes extra test at London Games
By Kate Kelland, Health and Science Correspondent
LONDON (Reuters)- When Malaysian cyclist Azizulhasni Awang opted to postpone his Ramadan fast until after the London ...
Mon, May 21, 2012
Fake drugs threaten gains made in war on malaria
By Kate Kelland
LONDON (Reuters) - Low-quality and fake anti-malarial drugs flooding into markets in Asia and Africa are driving drug resistance and threatening gains ...
Recent Comments